Single-Nucleotide Polymorphism-Based Noninvasive Prenatal Screening in a High Risk and Low-Risk Cohort

August 1, 2014
Back to Blog Home Page

We are pleased to announce our participation in Single-Nucleotide Polymorphism-Based Noninvasive Prenatal Screening in a High-Risk and Low-Risk Cohort.  Single_Nucleotide_Polymorphism_Based_Noninvasive.3

Baby KJ Makes Headlines as the First Infant to Receive Personalized CRISPR Gene Editing Therapy

Baby KJ Makes Headlines as the First Infant to Receive Personalized CRISPR Gene Editing Therapy

September 10, 2025
Read More
Alzheimer’s & Neurodegenerative Disease: A Global Challenge

Alzheimer’s & Neurodegenerative Disease: A Global Challenge

September 10, 2025
Read More
Mesenchymal Stem Cell Derived Exosomes: Revolutionizing Future Medical Treatments

Mesenchymal Stem Cell Derived Exosomes: Revolutionizing Future Medical Treatments

September 10, 2025
Read More

CGT Global Welcomes Dr. Jerome Ritz to Its Board of Advisors, Enriching Knowledge of Cellular Therapies and Hematology

August 14, 2025
Read More

CGT Global Appoints Dr. Andrew Branagan to Board of Advisors, Expanding Cell and Gene Therapy Expertise

August 11, 2025
Read More
Meet CGT Global's Scientific Team: Bryan Pulling – Laboratory Operations Manager Part II

Behind the Scenes at CGT Global’s Laboratory: Life in the Lab with Bryan

July 23, 2025
Read More